Child Anxiety Treatment: CBT, Medicine, and Parents

Child anxiety treatment often uses cognitive behavioral therapy, parent support, and help at school. Medicine can help when symptoms cause major distress or block daily life. The best plan fits the child’s age, diagnosis, needs, and choices. Treatment should build useful skills and include clear checks for progress and safety.

This article is for education. Your child’s care team should guide diagnosis and treatment choices.

What does child anxiety treatment involve?

Treatment starts with an assessment and a few clear goals. It then uses therapy, family changes, medicine, or a mix of these to help your child take part in daily life.

An anxiety disorder means fear or worry causes marked distress or gets in the way of life, beyond what fits the child’s age and situation. A child can need help even when they cannot explain what feels wrong.

Ask for goals you can see. These might include entering class, sleeping in their own bed, or asking a teacher for help. A lower worry score can matter, but so can joining lunch with friends.

The assessment should hear from your child as well as you. A teen may need time to speak in private, with clear limits when safety is at risk. The team should check sleep, health, learning, bullying, trauma, mood, and other needs. Those findings can change the plan.1

A child who fears leaving a parent may need work on separation anxiety. A child who expects judgment may need social anxiety treatment. Broad worries about grades, health, and mistakes can fit generalized anxiety. These can overlap, and age alone does not decide the diagnosis.

For more on signs by age, see anxiety at ages 5 to 8, ages 9 to 12, and the teen years. Here, the focus is what happens after you ask for care.

Zoom

How does CBT help an anxious child?

Cognitive behavioral therapy, or CBT, helps children test fearful predictions and practice things they avoid. Good anxiety treatment includes practice that fits the child’s abilities and real risks.

The therapist may first help your child name a fear: “If I ask a question, everyone will laugh.” They agree on a small, safe test. The child might ask the therapist a question, then a trusted teacher. They review what happened and choose the next step.

This practice is called exposure. It should have a clear purpose. It should not involve threats, shame, surprise scares, or unsafe situations. Your child needs a say in the plan. Tears or worry do not always mean the step is wrong, but the team should respond to distress and adjust when needed.

For young children, sessions may use play, drawings, and parent coaching. Older children can keep brief notes on what they predicted and learned. Teens should help choose goals that matter to them.

Think of a parent helping a child carry a full cup to the table. Holding the cup for them prevents spills today. Walking beside them as they learn gives them a chance to build skill. The analogy has limits: anxiety treatment also requires checking for real danger, disability, and needs that deserve lasting support.

Practice between visits matters. Ask the therapist what to try, how often, and what to do if the step is too hard. “Be brave this week” is less useful than a shared plan with one clear action.

A 2020 Cochrane review pooled 87 studies with 5,964 participants. CBT worked better than waiting or no treatment. Evidence against other active treatments was less clear, with limits in study size and quality. This supports offering CBT without claiming that one format wins for every child.2

Is CBT, medicine, or both most effective?

All three can help, and combined care produced the best short-term response in a major trial. That finding does not mean every child must start with both.

The Child/Adolescent Anxiety Multimodal Study, called CAMS, randomly assigned 488 children ages 7 to 17 to four groups. They had separation anxiety, generalized anxiety, social anxiety, or a mix. The medicine was sertraline, used off-label for these childhood anxiety disorders. CBT involved 14 sessions over 12 weeks.34

These are response rates within each group. Response meant clear improvement. It did not mean every symptom was gone or that anxiety could never return. CBT and sertraline each beat placebo. Their response rates did not differ significantly from one another.3

The 2020 child psychiatry guideline from AACAP makes these distinctions for ages 6 to 18. AACAP now lists guidelines older than five years for historical use.56 No newer AACAP anxiety guideline has replaced this one, so it is still the group’s most recent advice on this topic:

• It recommends CBT for social, generalized, separation, specific phobia, and panic disorders.
• It recommends an SSRI for social, generalized, separation, and panic disorders.
• It suggests that CBT plus an SSRI may be preferred to either alone for those four disorders.
• It suggests an SNRI as another option for those four disorders.1

The guideline came out before the 2023 escitalopram approval, so its medicine label details are out of date.17

“Recommends” and “suggests” reflect different strengths of guidance. The guideline does not require a fixed order for every child. Access, past care, severity, side effects, and family preference matter. Ask how the advice applies to your child’s exact diagnosis.

How can parents help without doing everything for the child?

Parents can show warmth while helping a child face planned, manageable steps. The goal is to change patterns that keep fear in charge of daily choices, without blaming the family.

Family accommodation means changing what you do to help a child avoid or reduce anxiety. You might answer the same worry question many times, speak for them in every setting, or cancel all trips apart. These choices make sense when you want to ease distress. Some can also leave fewer chances to practice coping.8

The SPACE approach works with parents on these patterns. Its name stands for Supportive Parenting for Anxious Childhood Emotions. Parents learn to accept their child’s distress and express trust in the child’s ability to cope. They plan changes rather than springing them on the child.

In a randomized study, 124 children ages 7 to 14 were assigned to SPACE or child CBT. SPACE involved 12 parent sessions without child sessions. It met the study’s rule for being no worse than CBT by a set amount. Parent accommodation fell more with SPACE. However, 97 families completed treatment, and most participants were White. One trial cannot show equal results for every child or family.8

Fictional composite: Maya, age 8. Maya cries when her father leaves for an evening class. Her parents have started canceling every plan apart. With coaching, they choose one brief separation with a trusted aunt. They explain it in advance and agree on a return time. They offer warmth and keep the plan small. Maya’s distress does not have to reach zero before they notice her effort.

A useful phrase might be, “I see how hard this feels. We have a plan, and I believe you can take this step.” This is a sample to adapt, not a script proven to work for every child.

Do not remove all support at once. A child may need language help, sensory changes, disability supports, or protection from bullying. These needs deserve assessment. Read more about reassurance and family accommodation.

Which anxiety medicines are FDA-approved for children?

Escitalopram and duloxetine have FDA approval for generalized anxiety disorder in children ages 7 and older. That approval does not extend to every childhood anxiety diagnosis.79

Some older medicines, such as hydroxyzine, have broad anxiety labels with child doses from decades ago.10 Those labels are not based on modern trials in children with anxiety disorders, and the AACAP guideline does not include them in its advice.1 Learn more about hydroxyzine for anxiety.

“Off-label” means a medicine is being used outside its FDA-approved condition or age group. That use can have research support. The clinician should explain the evidence and why it fits your child.

Sources: current prescribing information checked September 19, 2026.47911 OCD and depression approvals do not count as approval for all child anxiety disorders. Older pages may still say duloxetine is the only approved drug for pediatric GAD. That misses the expanded Lexapro label.

Medicine is a shared decision. Ask what problem it targets, what benefit to expect, what side effects to watch for, and when you will review progress. Tell the prescriber about other medicines and supplements. Also discuss any personal or family history of bipolar disorder.47911

These medicines are not instant calm pills. Review how your child is doing across several visits. Do not change a dose or stop treatment on your own. A sudden stop can cause withdrawal symptoms. The plan for stopping an antidepressant should be made with the prescriber.

What does the antidepressant boxed warning mean?

It means some young people have a higher risk of suicidal thoughts or behavior during antidepressant treatment. Families need a clear safety plan and follow-up, especially early in care and when doses change.

The Lexapro boxed warning states: “Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.”7

The current label’s pooled trial analysis reports 14 additional patients with suicidal thoughts or behaviors per 1,000 treated patients younger than 18, compared with placebo. This is an added risk, not the total number of affected patients. It does not describe 14 deaths.7

An FDA team also published its own review of the child and teen trials in 2006. It pooled 24 trials with 4,582 young people. It found an absolute risk increase of about 2 per 100 treated patients, with uncertainty from about 1 to 3 per 100. Most trials studied depression; others studied anxiety, OCD, or ADHD. No completed suicides occurred in those trials.12

Both figures come from FDA reviews of short-term trials in about 4,500 children and teens. They summarize the data in different ways, so do not add them together.712 Neither predicts exactly what will happen to your child. The decision also needs to weigh distress, lost function, and the risks of leaving an illness untreated.

Before starting, agree on whom to call during the day and after hours. Watch for new or worse agitation, severe restlessness, abrupt mood changes, impulsive acts, or suicidal thoughts. Report these promptly. For suicidal thoughts, call or text 988 right away, or call 911 if your child cannot be kept safe, then tell the prescriber. The prescriber should also track sleep, appetite, weight, and growth. The needed checks depend on the drug.47911

Make the home safer while treatment starts. Keep medicines locked away, and have an adult hand out each dose. The safest choice is to remove all guns and ammunition from the home. If guns stay, keep them locked and unloaded, with ammunition locked in a separate place.13

Ask calm, direct questions about safety. Make room for an honest answer without punishment. Do not wait for the next routine visit if a change worries you. See what families should watch for when an SSRI starts.

How is selective mutism treated?

Selective mutism treatment usually builds speech through small, planned steps across home, school, and therapy. The child can speak in some settings but cannot do so in others; pressure to perform can make the task harder.14

Care often brings together a mental health clinician, a speech-language pathologist, parents, and school staff. They check language skills, hearing, development, and the settings where speech is possible. A child learning a new language needs careful assessment before silence is labeled a disorder.14

Treatment can start with a person and place where speech already feels easier. A new person may join slowly. The child may practice sounds, words, and short answers in planned steps. Staff should protect ways to ask for basic needs and help, including written or other forms of communication.14

Fictional composite: Luis, age 13. Luis jokes with cousins at home but cannot speak in class. He uses writing to ask for help. His team checks both languages he uses and agrees on private speech practice with one trusted adult. Teachers stop calling on him without warning. They keep his writing support while they build safe chances to speak.

A 2023 review found 25 treatment studies, but only five randomized trials entered its meta-analysis. School and family approaches that used behavior practice showed promise. Evidence was less clear against other active treatments, and remission estimates were imprecise. This is a much smaller research base than the broad child anxiety literature.15

Can a school provide a 504 plan for anxiety?

An anxiety disorder may qualify a student for support under Section 504 when it substantially limits a major life activity, such as learning or speaking. Public schools, and other schools that get federal funds, must evaluate a student who needs or may need help because of a disability. A diagnosis alone does not decide eligibility or define the plan. The school also should not deny support just because medicine or therapy is helping.16

You can ask the school how to request an evaluation. Bring examples of what is hard: speaking, entering class, testing, eating at school, or asking for help. Include what helps and what has not worked.

Useful supports might include a named staff contact, a planned check-in, or a way to signal distress. These are examples to discuss, not a list that suits every student. The team should connect supports with access to learning and review whether they work.

A planned return to a feared task may be part of treatment. It must account for health, disability, trauma, and school safety. For the fuller attendance plan, see help for school refusal.

When should children be screened for anxiety?

The USPSTF recommends anxiety screening for children and teens ages 8 to 18, with a B grade. Its October 11, 2022 statement found too little evidence to recommend for or against routine screening at age 7 or younger.17

This guidance concerns children without known anxiety or recognized symptoms. It does not mean a younger child with distress should wait. Screening also does not make a diagnosis. A concerning result needs follow-up assessment and access to care.

What should a practical treatment plan include?

A useful plan names goals, who will help, what to practice, and when to review results. You should leave a visit knowing the next step, even if the full diagnosis is still being clarified.

1. Name the main problem. Ask which diagnosis fits and what else needs to be checked.
2. Pick two daily goals. Choose actions your child values, with their input.
3. Choose a starting treatment. Discuss CBT, parent work, medicine, and access limits.
4. Write the home and school plan. Keep steps small and protect needed supports.
5. Agree on safety checks. Set follow-up visits and a way to report changes between them.
6. Review function as well as scores. Notice attendance, sleep, friendships, and things your child can do again.

Bring past treatment notes and a list of medicines to the first psychiatric visit. If a plan stalls, ask what needs to change. The answer may involve the diagnosis, the practice tasks, side effects, access, or another unmet need.

Will anxiety come back after treatment?

It can, so follow-up and a plan for setbacks matter. Early improvement is valuable, but it does not promise lifelong freedom from anxiety.

The CAMELS follow-up assessed 288 of the original 488 CAMS participants, an average of 6.2 years later. At that visit, 134 of 288, or 46.5%, no longer had any of the anxiety disorders studied at entry. Children who responded early were more likely to be free of these disorders at follow-up. Still, almost half of the early responders (48%) had relapsed by then.18

Only 59% of the original group took part. Care changed over time, and the original treatment groups did not differ clearly in long-term remission. This was not a new randomized test of years of continuous treatment.18

Keep a short plan for what to do if avoidance grows again. It can name a skill to restart, a school contact, and when to return to care. If you need help choosing care, the anxiety care page explains how to ask for an assessment.

What we still don’t know

We cannot predict which child will do best with CBT, parent treatment, medicine, or a combination. Access and family context can change what is workable. Many trials exclude complex cases, and the strongest studies do not cover every age or diagnosis.138

Long-term medicine effects and the best way to prevent relapse need more study. Selective mutism trials remain small. Evidence for routine screening below age 8 is limited, even though symptomatic young children still need care.11517

When to get help now

Emergency: call 911 or go to the nearest emergency room if your child has attempted suicide, taken an overdose, has a plan or immediate intent to harm themselves or someone else, or cannot be kept safe. Do not leave them alone while arranging help.

Right now, any time: call or text 988 if your child has thoughts of suicide or is in an emotional crisis. This reaches the 988 Suicide & Crisis Lifeline in the U.S.

Same day: Contact the care team urgently for severe agitation, marked changes after a medicine starts, or several nights of little sleep with unusual energy or risky acts. If your child has new suicidal thoughts, call or text 988 right away, or call 911 if they cannot be kept safe. Then tell the care team the same day. If safety becomes uncertain, use emergency care.

Make an appointment: Seek care when fear keeps disrupting school, sleep, eating, friendships, or needed health care. Persistent silence in key settings also deserves assessment.

Key takeaways

• Set goals for daily life, not only worry scores.
• CBT includes planned practice with feared tasks.
• Parent treatment can reduce accommodation while keeping warmth and needed support.
• CAMS found the best short-term response with combined care; response was not a cure.
• Escitalopram and duloxetine have FDA approval for GAD from age 7.
• Antidepressant care needs clear safety checks and follow-up.
• School support and a relapse plan belong in the conversation.

Frequently asked questions

What is the best treatment for child anxiety?

CBT, parent support, and sometimes medicine can help. The right starting plan depends on the diagnosis, severity, age, access to therapy, and the child’s preferences. Combined CBT and sertraline had the highest short-term response in CAMS, but that does not mean every child needs both. Ask how progress and safety will be checked.

Can parents help if a child refuses therapy?

Yes. A clinician may offer work with parents even when a child will not attend sessions. SPACE teaches parents to respond with warmth and confidence while reducing some anxiety-related accommodation. It did about as well as child CBT in one trial. That trial did not focus on children who refuse care, but SPACE was built so parents can take part when a child will not. It still requires a trained clinician, a plan that fits the family, and attention to safety.

Is Lexapro approved for anxiety in children?

Yes. The U.S. Lexapro label includes generalized anxiety disorder in children ages 7 and older. That approval does not include every childhood anxiety disorder. Duloxetine also has approval for pediatric GAD from age 7. The choice between medicines needs a clinician’s review of the child’s needs, other treatments, possible harms, and follow-up plan.

Does an antidepressant warning mean my child should avoid medicine?

The warning calls for a careful decision and close follow-up. It does not decide the answer for every child. Discuss possible benefits, the risk of suicidal thoughts or behavior, and the effects of untreated illness. Agree on whom to call for changes, and get urgent help for new safety concerns rather than waiting for a routine visit.

Should I make my child speak if they have selective mutism?

Use a treatment plan with small speech goals instead of surprise demands or pressure in front of others. A team can help your child practice with trusted people and then expand to new settings. Keep safe ways to communicate needs. Assessment should also consider hearing, language skills, development, and whether the child is learning a new language.

Can a young child get help before age 8?

Yes. The uncertainty about routine screening below age 8 applies to children without recognized symptoms. A younger child with ongoing distress or trouble functioning should be assessed. Treatment should fit their development and often involves parents closely. Age limits on a screening recommendation are not rules that deny a symptomatic child care.

Related reading on NP FADY

• The Feelings Little Kids Can’t Name: Depression and Anxiety in Ages 5–8
• More Than Moodiness: Depression and Anxiety in Ages 9–12
• Behind the Closed Door: Depression and Anxiety in Teens Ages 13–18
• School Refusal Needs a Bridge Back, Not a Tug-of-War
• Specific Phobia Treatment: Flying, Needles, and More
• Starting an SSRI: What Families Should Watch For in the First Few Weeks
• IEP vs. 504 Plan: Understanding School Support Options for Students with Disabilities

References

1. Walter HJ, Bukstein OG, Abright AR, et al. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. Journal of the American Academy of Child & Adolescent Psychiatry. 2020;59(10):1107–1124. DOI: 10.1016/j.jaac.2020.05.005. PMID: 32439401. Guideline. AACAP treats guidelines older than five years as historical. No newer AACAP anxiety guideline was found as of September 2026.

2. James AC, Reardon T, Soler A, James G, Creswell C. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews. 2020;11:CD013162. DOI: 10.1002/14651858.CD013162.pub2. Official summary and abstract.

3. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine. 2008;359(26):2753–2766. DOI: 10.1056/NEJMoa0804633. Full text.

4. Viatris Specialty. Zoloft (sertraline) tablets and oral solution: U.S. prescribing information. DailyMed, version posted July 24, 2025. DailyMed label.

5. American Academy of Child and Adolescent Psychiatry. Practice Guidelines, Updates, and Parameters. AACAP website. Accessed September 19, 2026. AACAP policy page.

6. Editor’s Note: AACAP Guidelines, Updates, and Parameters. Journal of the American Academy of Child & Adolescent Psychiatry. Published online August 17, 2026. DOI: 10.1016/j.jaac.2026.07.1244. PMID: 42608867. Abstract.

7. Allergan. Lexapro (escitalopram) tablets and oral solution: U.S. prescribing information. DailyMed, version posted January 1, 2026. DailyMed label.

8. Lebowitz ER, Marin C, Martino A, Shimshoni Y, Silverman WK. Parent-Based Treatment as Efficacious as Cognitive Behavioral Therapy for Childhood Anxiety: A Randomized Noninferiority Study of Supportive Parenting for Anxious Childhood Emotions. Journal of the American Academy of Child & Adolescent Psychiatry. 2020;59(3):362–372. DOI: 10.1016/j.jaac.2019.02.014. Full text.

9. Eli Lilly and Company. Cymbalta (duloxetine) delayed-release capsules: U.S. prescribing information. DailyMed, version posted August 11, 2025. DailyMed label.

10. Chartwell RX. Hydroxyzine hydrochloride tablets: U.S. prescribing information. DailyMed, version posted December 12, 2025. DailyMed label.

11. Dista Products (Eli Lilly). Prozac (fluoxetine) capsules: U.S. prescribing information. DailyMed, version posted January 14, 2026. DailyMed label.

12. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry. 2006;63(3):332–339. DOI: 10.1001/archpsyc.63.3.332. Abstract.

13. Sigel EJ, Rahmandar MH. Suicide Prevention: 12 Things Parents Can Do. HealthyChildren.org, American Academy of Pediatrics. Updated October 7, 2024. Accessed September 19, 2026. AAP parent guidance.

14. American Speech-Language-Hearing Association. Selective Mutism. Practice Portal. Accessed September 19, 2026. Practice guidance.

15. Hipolito G, Pagnamenta E, Stacey H, et al. A systematic review and meta-analysis of nonpharmacological interventions for children and adolescents with selective mutism. JCPP Advances. 2023;3(3):e12166. DOI: 10.1002/jcv2.12166. Abstract.

16. U.S. Department of Education. Frequently Asked Questions: Section 504 Free Appropriate Public Education. Accessed September 19, 2026. Official guidance.

17. U.S. Preventive Services Task Force. Anxiety in Children and Adolescents: Screening. Final recommendation, October 11, 2022. Recommendation.

18. Ginsburg GS, Becker EM, Keeton CP, et al. Naturalistic follow-up of youths treated for pediatric anxiety disorders. JAMA Psychiatry. 2014;71(3):310–318. DOI: 10.1001/jamapsychiatry.2013.4186. Full text.

This article is for education and is not a substitute for care from a qualified health professional. Do not start, stop, or change medication without your prescriber’s guidance. Evidence last checked September 19, 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.